WilsonCMertensMDMSBA

PubMed

• 35 citations
  Strontium 89 therapy and relief of pain in patients with prostatic carcinoma metastatic to bone : a dose response relationship ?
  Wilson C. Mertens, Larry Stitt, Arthur T. Porter
  American Journal of Clinical Oncology. 1993-06-01
• 106 citations
  Weight gain following breast cancer diagnosis: Implication and proposed mechanisms.
  Grace Makari-Judson, Barry Braun, D. Joseph Jerry, Wilson C. Mertens
  World Journal of Clinical Oncology. 2014-08-10
• 92 citations
  Longitudinal patterns of weight gain after breast cancer diagnosis: observations beyond the first year.
  Grace Makari-Judson, Christopher H Judson, Wilson C. Mertens
  The Breast Journal. 2007-05-01

Journal Articles

• The treatment of hypercalcemia.  
  Mertens, W.C, Pain Management Newsletter
• Systemic radionuclides in the treatment of symptomatic bony metastases: The clinical trial era arrives.  
  Mertens, W.C., Porter, A.T., Int Oncol Monitor

Books/Book Chapters

• Adjuvant chemotherapy for soft tissue sarcomas. 
  Chapter: New Developments in the Multidisciplinary Approach to Treatment, 
  Page 93 - 103Mertens, W.C., Bramwell, V.H.CEditors: .M. Pinedo, J., Verweij, H. Suit, Norwell, M.A.Kluwer Academic Publishers
• Recent advances in radionuclide therapy of bone metastases. 
  Chapter: Nuclear Medicine Annual, L.M 
  Page 69 - 89Mertens, W.C., Reid, R.H., Porter, A.T., Powe, J.EEditors: Freeman.New York, Raven Press
• Adjuvant chemotherapy for soft tissue sarcomas. 
  Chapter: Multidisciplinary Treatment of Soft Tissue Sarcomas 
  Page 117 - 134Mertens, W.C., Bramwell, V.H.CEditors: H.M. Pinedo, J., Verweij, H., H. Suit Norwell, M.A..Kluwer Academic Publishers
• Combination of chronic indomethacin and intermittent interleukin-2 therapy in the treatment of disseminated cancer. 
  Chapter: Combination Therapies 2 
  Page 155 - 165Lala, P.K., Al-Mutter, N., Parhar, R.S., Saarloos, M.N., Banerjee, D., Bramwell, V., Mertens, W.CEditors: A.L., Goldstein, E. Garaci.Plenum Press, New York
• Brown’s Otolaryngology, Vol. 1, Basic Sciences. 
  Chapter: Cancer Biology 
  Mertens, W.CEditors: M.Gleeson.Butterworth Heinemann, Oxford
• Chemotherapy for Soft Tissue Sarcomas. 
  Chapter: Surgery for Musculoskeletal Tumors 
  Mertens, W.C., Bramwell, V.H.CEditors: M. Simon, D. Springfield.J.B Lippincott, Philadelphia, PA
• Cancer Biology. 
  Chapter: Scott-Brown’s Otolaryngology 
  Mertens, W.CEditors: Student’s Edition, A.G. Kerr.Butterworth-Heinemann, Oxford
• Prostate Cancer. 
  Chapter: Metastatic Disease to the Musculoskeletal System. Heiner 
  Page 303 - 316Porter, A.T., Ben-Josef, E., Mertens, W.C., Ryan, J.REditors: J., Kinsella, T., Zdeblick, T.Quality Medical Publishing, St. Louis, MO
• Clinical Aspects and Management of Anal Cancer. 
  Chapter: Gastrointestinal Oncology 
  Gaspar, L.E., Mertens, W.C., Raben D., Evans, SEditors: Abbruzzese, J.L, Evans, D.B., Willett, C, Feoglio-Preiser, C.Oxford University Press, New York
• Join now to see all

Abstracts/Posters

• Differential aspects of sleep epilepsy.
  Young, G.B., Blume, W.T., Wells, G.A., Mertens, W.C., Eder, S, Can J. Neurol Sci
• Pre-and post-operative chemotherapy for soft tissuee sarcoma.
  Mertens, W. Bramwell, V, Proc Joint Warsaw Workshop on Adjuvant chemotherapy, Poland
• Strontium-89 in the treatment of metastatic prostate carcinoma.
  Porter, A.T., Mertens, W.C, Can. J. Oncol
• Continuous indomethacin and ranitidine with continuous venous infusioninterleukin-2 in advanced renal carcinoma and melanoma: A preliminary report.
  Mertens, W.C., Bramwell, V.H.C., Lala, P.K., Banerjee, D., Gwadry-Sridhar, F., Romano, W, Can J. Infect Dis
• Biologic response modifiers - A review.
  Gwadry-Sridhar, F., Mertens, W, On Continuing Practice, Ontario College of Pharmacy
• Phase II study of sulofenur (LY186641) in measurable metastatic renal cancer.
  Weinerman, B., Eisenhauer, E., Stewart, D., Mertens, W., Tannock, I., Venner, P.,Spaulding, R, Ann Oncol, National Cancer Institute of Canada
• Effect of indomethacin plus ranitidine in advanced melanoma patients on high-dose interleukin-2.
  Mertens, W.C., Bramwell, V.H.C., Gwadry-Sridhar, F., Romano, W., Banerjee, D.,Lala, P.K, Lancet
• Strontium 89 and low dose infusion cisplatin for patients with hormone refractory prostate carcinoma metastatic to bone: A preliminary report.
  Mertens, W.C., Porter, A.T., Reid, R.H., Powe, J.E, J. Nucl Med
• Adjuvant chemotherapy in the treatment of soft tissue sarcoma.
  10. Mertens, W.C., Bramwell, V.H.C, Clin Orthop
• Gemcitabine in advanced renal cell carcinom.
  11. Mertens, W.C., Eisenhauer, E.A., Moore, M., Venner, P., Stewart, D., Mudal, A.,Wong, D, Ann Oncol, National Cancer Institute of Canada Clinical Trials Group
• Sustained indomethacin and ranitidine with intermittent continuous infusion interleukin-2 in advanced malignant melanoma: A phase II study.
  12. Mertens, W.C., Bramwell, V.H.C., Banerjee, D., Gwadry-Sridhar, F. Lala, P.K, Clin Oncol
• Strontium 89 and relief of pain in patients with prostatic carcinoma metastatic to bone: A dose response relationship.
  Mertens, W.C., Stitt, L., Porter, A.T, Am J Clin Oncol
• Adult soft tissue sarcomas.
  Mertens, W.C., Bramwell, V.H.C, Curr Opin Oncol
• Sustained oral indomethacin and ranitidine with continuous infusion interleukin-2 in advanced renal cell carcinoma.
  Mertens, W.C., Bramwell, V.H.C., Banerjee, D., Gwadry-Sridhar, F., Al-Mutter, N., Parhar, R.S., Lala, P.K, Cancer Biotherapy
• Osteosarcoma and other tumors of bone.
  17. Mertens, W.C., Bramwell, V.H.C, Curr Opin Oncol
• Docetaxel in advanced renal cell carcinoma.
  18. Mertens. W.C., Eisenhauer, E.A., Jolivet, J., Ernst, S., Moore, M., Muldal A, Ann Oncol, National Cancer Institute of Canada Clinical Trials Group
• Utility of indium-111 labeled leukocytes in patients completing high dose interleukin-2 therapy: A pilot study.
  19. Mertens, W.C., Powe, J.E, Nucl Med Commun
• Glutathione S-transferase expression in renal cell carcinoma: A new marker of differentiation.
  20. Grignon, D.J., Abdel-Malak, M., Mertens, W.C., Shepherd, R.R, Mod Pathol
• Adjuvant chemotherapy of soft tissue sarcoma.
  Mertens, W.C., Bramwell, V.H.C, Hematol Oncol Clin North Amer
• Prognostic significance of cellular proliferation in renal cell carcinoma: A comparison of S-phase fraction and PCNA index.
  Grignon, D.J., Abdel-Malek, M., Mertens, W., Koster, J., Keeney, M., Sakr, W., Shepherd, R.R, Mod Pathol
• Osteosarcoma and other tumors of bone.
  23. Mertens, W.C., Bramwell, V.H.C, Curr Opin Oncol
• sulfhydryl transferase ? expression in testicular germ cell tumors: an immunohistochemical study of 30 cases.
  24. Grignon, D.J., Mertens, W.C, Oncol Rep
• High dose continuous venous infusion interleukin-2: influence of dose and infusion rate on tumoricidal function and lymphocyte subsets.
  25. Mertens, W.C., Banerjee, D., Al-mutter, N. Stitt, L., Bramwell, V.H.C., Lala, P.K, Cancer Immunol Immunother
• Osteosarcoma and other tumors of bone.
  Mertens, W.C., Bramwell, V.H.C, Curr Opin Oncol
• Oral indomethacin and ranitidine in advanced melanoma: a phase II study.
  Mertens. W.C., Lohmann, R.C, Clin. Oncol
• Join now to see all

Lectures

• Breast and head and neck cancer: current controversies, treatments, and outcome measures. 
  American Academy of Physical Medicine and Rehabilitation, Phoenix, AZ
• Marketing Oncology: Service Line Strategies for Marketers. 
  HCPro Healthcare Marketplace. Webinar
• Patient Experience Design: An Experience Report. 
  LEAP Forward Conference, Park City, UT
• The Cancer Patient Experience: Market Competitiveness and Patient Satisfaction. 
  Optimizing Cancer Center Management Conference. Washington, DC
• Ambulatory Care Facilities Planning: The Evolution of the Care Practice, Technology and Design Drivers of Key Health Care Portals. 
  Harvard University Graduate School of Design, Boston, MA
• Experience Design and Patient Satisfaction. 
  Siemens Navigators’ Circle, Disney Institute, Orlando, FL
• Experience design for Centers of Excellence: Facilities and Programs. 
  Neuroscience Centers of Excellence. Las Vegas, NV February 28-March 1, 2006
• Re-imagining your cancer program as “great”: Pathways to a shared vision. 
  International National Conference on Developing Cancer Centers of Excellence. New York, NY
• Re-engineering the patient experience as an instrument for competitive advantage. 
  Neuroscience Centers of Excellence, Las Vegas, NV February 28-March 2, 2005
• Integrating your existing programs into a cancer program “center of excellence”: redefining culture to create a patient experience. 
  World Research Group, Las Vegas, NV
• Creating a Patient Experience: The D’Amour Center for Cancer Care. 
  Harvard University Graduate School of Design Review Course, Boston MA
• Radionuclide therapy of bone metastases: Prospects for enhancement of therapeutic efficacy. 
• Integrating Existing Programs into a “Center of Excellence”: Redefining Culture in a Cancer Program. World Research Group Revenue Cycle Series. 
  Building and Streamlining Neuroscience Centers of Excellence, Las Vegas, NV
• Centers of Excellence Development: The Journey of a Cancer Program. Active Communications International 4th National Conference on Adding, Updating and Expanding Neuro... 
  Boston, MA
• Developing a Cancer Center Experience. In “The Six Ways of an Experience Producer” Presented at the Annual Meeting, Society for Healthcare Strategy and Market Developm... 
  American Hospital Association, Atlanta, GA
• Models of Failure: Lessons from Industry. 
  LENT IV Consensus Conference, St. Petersburg, FL
• Aggressive Ambulatory Narcotic Management of Sickle Cell Disease-Associated Pain—barriers, impact and future. 
  Portland Health Sciences Center, Portland, OR
• Radionuclide therapy of bone metastases: Improving the therapeutic index. Advances in the treatment of metastatic prostate cancer. Symposium given at the annual mee... 
  Miami, Fl
• Management of the patient with testicular cancer. Urology Nurses of Canada 6th Annual Conference. 
  London, Canada
• Interleukin-2 in cancer treatment. Cancer Treatment and Research Treatment. 
  Foundation of Nova Scotia, Halifax, Nova Scotia
• Interleukin-2 in therapy of advanced malignancy. 
  Princess Margaret Hospital, Toronto, Ontario
• Join now to see all

Other

• The importance of spiritual counseling in the care of cancer patients. 
  Mertens, W.C
  http://www.plainviews.org/AR/i/v1n15.html#1